1,3,5-Triazines: A promising scaffold for anticancer drugs development
Publication type: Journal Article
Publication date: 2017-12-01
scimago Q1
wos Q1
SJR: 1.142
CiteScore: 11.3
Impact factor: 5.9
ISSN: 02235234, 17683254
PubMed ID:
29046238
Organic Chemistry
Drug Discovery
General Medicine
Pharmacology
Abstract
This review covering literature reports from the beginning of this century to 2016 describes the synthetic pathways, the antitumor activity, the structure-activity relationship and, whenever reported, the possible mechanism of action of 1,3,5-triazine derivatives as well as of their hetero-fused compounds. Many 1,3,5-triazine derivatives, both uncondensed and hetero-fused, have shown remarkable antitumor activities and some of them reached clinical development.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
8
9
|
|
|
Molecules
9 publications, 6.87%
|
|
|
Journal of Molecular Structure
8 publications, 6.11%
|
|
|
Bioorganic Chemistry
6 publications, 4.58%
|
|
|
RSC Advances
6 publications, 4.58%
|
|
|
ACS Omega
5 publications, 3.82%
|
|
|
Russian Journal of General Chemistry
5 publications, 3.82%
|
|
|
European Journal of Medicinal Chemistry
4 publications, 3.05%
|
|
|
Journal of Heterocyclic Chemistry
3 publications, 2.29%
|
|
|
New Journal of Chemistry
3 publications, 2.29%
|
|
|
Advanced healthcare materials
3 publications, 2.29%
|
|
|
Журнал Общей Химии
3 publications, 2.29%
|
|
|
Current Medicinal Chemistry
2 publications, 1.53%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.53%
|
|
|
Structural Chemistry
2 publications, 1.53%
|
|
|
ChemistrySelect
2 publications, 1.53%
|
|
|
European Journal of Organic Chemistry
2 publications, 1.53%
|
|
|
Journal of Medicinal Chemistry
2 publications, 1.53%
|
|
|
Dalton Transactions
2 publications, 1.53%
|
|
|
Molecular Crystals and Liquid Crystals
2 publications, 1.53%
|
|
|
Advances in Heterocyclic Chemistry
2 publications, 1.53%
|
|
|
Mendeleev Communications
2 publications, 1.53%
|
|
|
Chemistry and Biodiversity
2 publications, 1.53%
|
|
|
Mini-Reviews in Organic Chemistry
1 publication, 0.76%
|
|
|
Current Organic Chemistry
1 publication, 0.76%
|
|
|
Current Topics in Medicinal Chemistry
1 publication, 0.76%
|
|
|
Canadian Journal of Chemistry
1 publication, 0.76%
|
|
|
Journal of Fire Sciences
1 publication, 0.76%
|
|
|
Cancers
1 publication, 0.76%
|
|
|
Frontiers in Chemistry
1 publication, 0.76%
|
|
|
1
2
3
4
5
6
7
8
9
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
Elsevier
34 publications, 25.95%
|
|
|
Wiley
18 publications, 13.74%
|
|
|
MDPI
14 publications, 10.69%
|
|
|
American Chemical Society (ACS)
13 publications, 9.92%
|
|
|
Royal Society of Chemistry (RSC)
11 publications, 8.4%
|
|
|
Springer Nature
9 publications, 6.87%
|
|
|
Pleiades Publishing
8 publications, 6.11%
|
|
|
Bentham Science Publishers Ltd.
5 publications, 3.82%
|
|
|
Taylor & Francis
5 publications, 3.82%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 1.53%
|
|
|
Canadian Science Publishing
1 publication, 0.76%
|
|
|
SAGE
1 publication, 0.76%
|
|
|
Frontiers Media S.A.
1 publication, 0.76%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.76%
|
|
|
Walter de Gruyter
1 publication, 0.76%
|
|
|
Scientific Research Publishing
1 publication, 0.76%
|
|
|
The Japan Institute of Heterocyclic Chemistry
1 publication, 0.76%
|
|
|
Eco-Vector LLC
1 publication, 0.76%
|
|
|
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
1 publication, 0.76%
|
|
|
Japanese Society for Bacteriology
1 publication, 0.76%
|
|
|
Hindawi Limited
1 publication, 0.76%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 0.76%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
131
Total citations:
131
Citations from 2025:
16
(12.21%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Cascioferro S. et al. 1,3,5-Triazines: A promising scaffold for anticancer drugs development // European Journal of Medicinal Chemistry. 2017. Vol. 142. pp. 523-549.
GOST all authors (up to 50)
Copy
Cascioferro S., Parrino B., Spanò V., Carbone A., Montalbano A., Barraja P., Diana P., Cirrincione G. 1,3,5-Triazines: A promising scaffold for anticancer drugs development // European Journal of Medicinal Chemistry. 2017. Vol. 142. pp. 523-549.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.ejmech.2017.09.035
UR - https://doi.org/10.1016/j.ejmech.2017.09.035
TI - 1,3,5-Triazines: A promising scaffold for anticancer drugs development
T2 - European Journal of Medicinal Chemistry
AU - Cascioferro, Stella
AU - Parrino, Barbara
AU - Spanò, Virginia
AU - Carbone, Anna
AU - Montalbano, Alessandra
AU - Barraja, Paola
AU - Diana, Patrizia
AU - Cirrincione, Girolamo
PY - 2017
DA - 2017/12/01
PB - Elsevier
SP - 523-549
VL - 142
PMID - 29046238
SN - 0223-5234
SN - 1768-3254
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Cascioferro,
author = {Stella Cascioferro and Barbara Parrino and Virginia Spanò and Anna Carbone and Alessandra Montalbano and Paola Barraja and Patrizia Diana and Girolamo Cirrincione},
title = {1,3,5-Triazines: A promising scaffold for anticancer drugs development},
journal = {European Journal of Medicinal Chemistry},
year = {2017},
volume = {142},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/j.ejmech.2017.09.035},
pages = {523--549},
doi = {10.1016/j.ejmech.2017.09.035}
}